AbCellera Biologics (ABCL) Amortizatization of Intangibles (2020 - 2026)

AbCellera Biologics has reported Amortizatization of Intangibles for 7 years, with the latest figure at $920000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles changed 0.22% year-over-year to $920000.0; the trailing twelve-month figure through Mar 2026 stood at $6.6 million (down 91.43% YoY), and the FY2025 full-year result was $6.6 million, down 91.51% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $920000.0, down from $1.8 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $73.5 million in Q4 2024, with the low at -$30.0 million in Q3 2024.
• Historically, Amortizatization of Intangibles has averaged $6.8 million across 5 years, with a median of $1.7 million in 2024.
• The largest YoY upside for Amortizatization of Intangibles was 1912.57% in 2024 against a maximum downside of 1221.3% in 2024.
• AbCellera Biologics' Amortizatization of Intangibles stood at $15.2 million in 2022, then slumped by 75.98% to $3.7 million in 2023, then soared by 1912.57% to $73.5 million in 2024, then plunged by 97.56% to $1.8 million in 2025, then plunged by 48.8% to $920000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $920000.0 (Q1 2026), $1.8 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.